Balyasny Asset Management
NVRO

Balyasny Asset Management’s NEVRO CORP. NVRO Stock Holding History

Balyasny Asset Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-65,000
Closed -$2.35M – 2905
2023
Q1 		$2.35M Buy
+65,000
New +$2.28M 0.01% 1398
2022
Q4 		– Sell
-334,700
Closed -$15.6M – 3320
2022
Q3 		$15.6M Buy
+334,700
New +$15.5M 0.05% 513

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Balyasny Asset Management's NVRO Position: Q4 2024 in Review

Balyasny Asset Management sold out of NEVRO CORP. (NVRO) in Q4 2024, closing a stake of 505,295 shares — an estimated $2.82M sold.

Balyasny Asset Management first reported a position in NVRO in Q2 2016 and held it in 31 quarters. The position peaked at $38.4M in Q4 2019. 129 funds tracked by Wall St. Rank hold NVRO as of Q4 2024.

  • Balyasny Asset Management reported no remaining NEVRO CORP. position as of Q4 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 505,295 NEVRO CORP. shares in Q4 2024, an estimated $2.82M.
  • Balyasny Asset Management first reported a position in NEVRO CORP. in Q2 2016 and held it in 31 quarters.
  • Balyasny Asset Management's NEVRO CORP. position peaked at $38.4M in Q4 2019.
  • 129 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2024.

Based on Balyasny Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.